611 W. Union Street
Benson, AZ 85602
(520) 586-0800

LaFrontera
member support line
1-520-279-5737
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
What You Need to Know About Your Colon Cancer RiskNewer Rheumatoid Arthritis Drug May Help Ease Tough-to-Treat CasesCelebrate Autumn Traditions Without Raising Your COVID RiskNew Drug Could Extend Life for People With ALSHeart Defects Don't Increase Risk of Severe COVID-19Chinese COVID Vaccine Shows Promise in Early TrialAmerica Sees Daily COVID Cases Pass 60,000 Once AgainCOVID Scored Big at 'Superspreader' Hockey GameAHA News: Belly Fat May Signal Early Heart Issues for Mexican AmericansFDA Approves First Ebola Virus TreatmentAmericans Might Need to Pass on Thanksgiving Gatherings: FauciAHA News: Flu and COVID-19 Are Bad Enough, But They Also Can Raise Stroke RiskYour Blood Type May Predict Your Risk For Severe COVID-19Newborns of Moms With COVID-19 Face Little Infection Risk: StudyCOVID Cases Climbing in 36 StatesBedside COVID-19 Test Faster Than Standard PCR TestNIH Launches Trial of Antibody Drugs Against COVID-19Long-Lasting Immunity Seems to Follow Serious COVID CasesAHA News: How Much Do You Know About Thrombosis? Probably Not EnoughCOVID-19 Taking Huge Toll in Excess U.S. DeathsSecond COVID Vaccine Trial Paused for Unexplained IllnessBlacks, Asians More Likely Than Whites to Have Severe COVIDUpper Midwest Sees COVID-19 Surge as Northeast Worries About a Second WaveRemdesivir Speeds Recovery for COVID PatientsAnimal Study Points to Heating Coil Behind Serious Vaping InjuriesAHA News: Strokes and Heart Attacks Increase When Flu-Like Illnesses RiseZika Epidemic Was More Widespread Than Thought: StudyVirtual Care After Surgery May Be More Convenient For PatientsAlways Be Ready for a Trip to the ERPandemic Silver Lining: Steep Drop in Kids' FracturesAntibiotics May Be Best First Treatment for AppendicitisResearchers Identify Bacteria Responsible for Key Crohn's ComplicationDuring and After Surgery, Pot Users Need More Anesthesia, Painkillers: StudyHeart Patients Need to Be Wary of CoronavirusWearing a Mask Doesn't Cause CO2 PoisoningCOVID-19 ICU Patients Have High Risk of Clots, Research ShowsGot Sciatica? Stay Active and Start Early on Physical TherapyDrug Combo Approved for First-Line Treatment of Mesothelioma8 in 10 COVID-19 Patients Suffer Neurological Symptoms, Study FindsAs Virtual Doctor Visits Spike, Concerns About Equity, Missed Diagnoses GrowFor Maximum Safety, Be Sure to Wash Your Homemade Face Mask: StudyDo Minority Kids Face More Danger During Surgeries?Why Getting a Flu Shot is More Important Than Ever This FallCommon Heartburn Meds Tied to Higher Diabetes RiskCOVID-19 Antibodies Decline Quickly in Donated Plasma: StudyNormal Conversation Spreads Virus-Laden Droplets Beyond 6 FeetPresident Trump, First Lady Test Positive for CoronavirusGenetics Might Explain Some Cases of Cerebral PalsyWith 'Twindemic' Looming, 2 out of 5 Americans Plan to Skip Flu ShotLast-Ditch Life Support System Is Saving Lives of COVID Patients
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

COVID-19 Antibodies Decline Quickly in Donated Plasma: Study

HealthDay News
by -- Robert Preidt
Updated: Oct 2nd 2020

new article illustration

FRIDAY, Oct. 2, 2020 (HealthDay News) -- Antibodies against COVID-19 in people who've recovered from the disease begin to vanish about three months after they develop symptoms, researchers say.

This suggests that sooner is better for recovered COVID-19 patients to donate antibody-containing blood plasma for convalescent plasma treatment, according to the authors of a small study published Oct. 1 in the journal Blood.

"Based on our findings, antibodies against the new coronavirus are not eternal," said study author Renée Bazin, director of innovation at Canada-based Héma-Quebec blood center.

Bazin's team said their findings may prove important for creating vaccines and research into how many people have recovered from COVID-19.

In convalescent plasma treatment, plasma from recovered patients is given to newly ill patients in an attempt to boost their ability to fight the virus.

"While many clinical trials are underway to better understand whether convalescent plasma is clinically beneficial for treating COVID-19, a key question is at what time point is it most effective to collect donor plasma based on the presence of antibodies that help fight the virus," Bazin said in a news release from the American Society of Hematology.

The study included 15 adults who recovered from COVID-19. Their symptoms ranged from mild to severe, but none were hospitalized.

Each person donated plasma between four and nine times. The first donation was 33 to 77 days after symptoms began, and the last donation was made between 66 and 114 days.

By about 88 days, all 15 donors had decreases in antibodies, and half of detectable antibodies dropped within 21 days after that, the investigators found.

"The antibodies disappear rapidly, so people recovering from COVID-19 who want to donate blood plasma should not wait too long once they become eligible to donate," Bazin said.

Based on these findings, she said clinicians should check for presence of antibodies before giving donor plasma to a patient.

More information

The U.S. Centers for Disease Control and Prevention has more on COVID-19.